| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | DNA-binding transcription factor activity, RNA polymerase II-specific | ZNF492 ZNF600 ZNF117 ZNF852 ZNF341 ZNF43 ZNF549 NR4A2 ZNF724 ADNP2 ZNF816 ZNF521 NR4A3 ZBTB41 ZNF510 ZNF860 SNAI1 NR4A1 ZNF468 ZBTB11 LHX6 ZNF98 ZIM3 ZNF583 ZNF879 PRDM1 | 8.39e-11 | 1412 | 85 | 26 | GO:0000981 |
| GeneOntologyMolecularFunction | RNA polymerase II transcription regulatory region sequence-specific DNA binding | ZNF492 ZNF600 ZNF117 ZNF852 ZNF341 ZNF43 ZNF549 ZNF335 NR4A2 ZNF724 ZNF816 ZNF521 NR4A3 ZBTB41 ZNF510 ZNF860 SNAI1 NR4A1 ZNF468 ZBTB11 LHX6 ZNF98 ZIM3 ZNF583 ZNF879 PRDM1 | 1.72e-10 | 1459 | 85 | 26 | GO:0000977 |
| GeneOntologyMolecularFunction | RNA polymerase II cis-regulatory region sequence-specific DNA binding | ZNF492 ZNF600 ZNF117 ZNF852 ZNF341 ZNF43 ZNF549 ZNF335 NR4A2 ZNF724 ZNF816 ZNF521 NR4A3 ZBTB41 ZNF860 SNAI1 NR4A1 ZNF468 ZBTB11 ZNF98 ZIM3 ZNF583 ZNF879 PRDM1 | 2.13e-10 | 1244 | 85 | 24 | GO:0000978 |
| GeneOntologyMolecularFunction | cis-regulatory region sequence-specific DNA binding | ZNF492 ZNF600 ZNF117 ZNF852 ZNF341 ZNF43 ZNF549 ZNF335 NR4A2 ZNF724 ZNF816 ZNF521 NR4A3 ZBTB41 ZNF860 SNAI1 NR4A1 ZNF468 ZBTB11 ZNF98 ZIM3 ZNF583 ZNF879 PRDM1 | 3.29e-10 | 1271 | 85 | 24 | GO:0000987 |
| GeneOntologyMolecularFunction | nuclear glucocorticoid receptor binding | 8.05e-05 | 20 | 85 | 3 | GO:0035259 | |
| GeneOntologyMolecularFunction | glial cell-derived neurotrophic factor receptor activity | 1.78e-04 | 5 | 85 | 2 | GO:0016167 | |
| GeneOntologyMolecularFunction | thioredoxin-disulfide reductase (NADPH) activity | 3.71e-04 | 7 | 85 | 2 | GO:0004791 | |
| GeneOntologyMolecularFunction | zinc ion binding | TCEA1 TCEA2 TCEA3 ZNF117 ADAMTS2 NR4A2 KMT2A NR4A3 NR4A1 PHF8 ZMYM4 NUP153 | 3.79e-04 | 891 | 85 | 12 | GO:0008270 |
| GeneOntologyMolecularFunction | transition metal ion binding | TXNRD1 TCEA1 TCEA2 TCEA3 ZNF117 ADAMTS2 NR4A2 KMT2A CYP4F22 NR4A3 NR4A1 PHF8 ZMYM4 NUP153 | 4.67e-04 | 1189 | 85 | 14 | GO:0046914 |
| GeneOntologyMolecularFunction | protein-disulfide reductase (NAD(P)H) activity | 6.32e-04 | 9 | 85 | 2 | GO:0047134 | |
| GeneOntologyMolecularFunction | glycosaminoglycan binding | 9.97e-04 | 268 | 85 | 6 | GO:0005539 | |
| GeneOntologyMolecularFunction | serine-type exopeptidase activity | 1.15e-03 | 12 | 85 | 2 | GO:0070008 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on a sulfur group of donors, NAD(P) as acceptor | 1.15e-03 | 12 | 85 | 2 | GO:0016668 | |
| GeneOntologyMolecularFunction | nuclear receptor activity | 2.14e-03 | 60 | 85 | 3 | GO:0004879 | |
| GeneOntologyMolecularFunction | ligand-activated transcription factor activity | 2.24e-03 | 61 | 85 | 3 | GO:0098531 | |
| GeneOntologyMolecularFunction | sulfur compound binding | 2.56e-03 | 323 | 85 | 6 | GO:1901681 | |
| GeneOntologyMolecularFunction | histone methyltransferase binding | 2.62e-03 | 18 | 85 | 2 | GO:1990226 | |
| GeneOntologyBiologicalProcess | cellular response to corticotropin-releasing hormone stimulus | 1.20e-06 | 6 | 82 | 3 | GO:0071376 | |
| GeneOntologyBiologicalProcess | response to corticotropin-releasing hormone | 1.20e-06 | 6 | 82 | 3 | GO:0043435 | |
| Domain | Znf_C2H2 | ZNF492 ZNF800 ZNF600 ZNF117 ZNF852 ZNF341 ZNF43 ZNF549 ZNF335 TAX1BP1 ADNP2 ZNF816 ZNF521 ZBTB41 ZNF510 ZNF860 SNAI1 ZNF468 ZBTB11 ZNF98 ZIM3 ZNF583 ZNF879 ZNF702P PRDM1 | 1.28e-14 | 805 | 86 | 25 | IPR007087 |
| Domain | ZnF_C2H2 | ZNF492 ZNF800 ZNF600 ZNF117 ZNF852 ZNF341 ZNF43 ZNF549 ZNF335 TAX1BP1 ADNP2 ZNF816 ZNF521 ZBTB41 ZNF510 ZNF860 SNAI1 ZNF468 ZBTB11 ZNF98 ZIM3 ZNF583 ZNF879 ZNF702P PRDM1 | 1.39e-14 | 808 | 86 | 25 | SM00355 |
| Domain | ZINC_FINGER_C2H2_2 | ZNF492 ZNF800 ZNF600 ZNF117 ZNF852 ZNF341 ZNF43 ZNF549 ZNF335 ADNP2 ZNF816 ZNF521 ZBTB41 ZNF510 ZNF860 SNAI1 ZNF468 ZBTB11 ZNF98 ZIM3 ZNF583 ZNF879 ZNF702P PRDM1 | 5.19e-14 | 775 | 86 | 24 | PS50157 |
| Domain | ZINC_FINGER_C2H2_1 | ZNF492 ZNF800 ZNF600 ZNF117 ZNF852 ZNF341 ZNF43 ZNF549 ZNF335 ADNP2 ZNF816 ZNF521 ZBTB41 ZNF510 ZNF860 SNAI1 ZNF468 ZBTB11 ZNF98 ZIM3 ZNF583 ZNF879 ZNF702P PRDM1 | 5.49e-14 | 777 | 86 | 24 | PS00028 |
| Domain | zf-C2H2_6 | ZNF492 ZNF600 ZNF117 ZNF852 ZNF43 ZNF549 ZNF816 ZNF521 ZBTB41 ZNF860 SNAI1 ZNF468 ZBTB11 ZNF98 ZIM3 ZNF879 PRDM1 | 6.21e-14 | 314 | 86 | 17 | PF13912 |
| Domain | Znf_C2H2-like | ZNF492 ZNF800 ZNF600 ZNF117 ZNF852 ZNF341 ZNF43 ZNF549 ZNF335 TAX1BP1 ADNP2 ZNF816 ZNF521 ZBTB41 ZNF510 ZNF860 SNAI1 ZNF468 ZBTB11 ZNF98 ZIM3 ZNF583 ZNF879 PRDM1 | 9.28e-14 | 796 | 86 | 24 | IPR015880 |
| Domain | - | ZNF492 ZNF800 ZNF600 ZNF117 ZNF852 ZNF341 ZNF43 ZNF549 ZNF335 ZNF816 ZNF521 ZBTB41 ZNF510 ZNF860 SNAI1 ZNF468 ZBTB11 ZNF98 ZIM3 ZNF583 ZNF879 PRDM1 | 2.93e-13 | 679 | 86 | 22 | 3.30.160.60 |
| Domain | zf-C2H2 | ZNF492 ZNF600 ZNF117 ZNF852 ZNF341 ZNF43 ZNF549 ZNF335 ZNF816 ZNF521 ZBTB41 ZNF510 ZNF860 SNAI1 ZNF468 ZBTB11 ZNF98 ZIM3 ZNF583 ZNF879 ZNF702P PRDM1 | 4.41e-13 | 693 | 86 | 22 | PF00096 |
| Domain | Znf_C2H2/integrase_DNA-bd | ZNF492 ZNF800 ZNF600 ZNF117 ZNF852 ZNF341 ZNF43 ZNF549 ZNF335 ZNF816 ZNF521 ZBTB41 ZNF510 ZNF860 SNAI1 ZNF468 ZBTB11 ZNF98 ZIM3 ZNF583 ZNF879 PRDM1 | 4.54e-13 | 694 | 86 | 22 | IPR013087 |
| Domain | KRAB | ZNF492 ZNF852 ZNF43 ZNF549 ZNF816 ZNF510 ZNF860 ZNF468 ZNF98 ZIM3 ZNF583 ZNF879 | 8.76e-08 | 358 | 86 | 12 | PS50805 |
| Domain | KRAB | ZNF492 ZNF852 ZNF43 ZNF549 ZNF816 ZNF510 ZNF860 ZNF468 ZNF98 ZIM3 ZNF583 ZNF879 | 8.76e-08 | 358 | 86 | 12 | PF01352 |
| Domain | TFSII | 9.43e-08 | 3 | 86 | 3 | IPR006289 | |
| Domain | Nuc_orph_rcpt | 9.43e-08 | 3 | 86 | 3 | IPR003070 | |
| Domain | KRAB | ZNF492 ZNF852 ZNF43 ZNF549 ZNF816 ZNF510 ZNF860 ZNF468 ZNF98 ZIM3 ZNF583 ZNF879 | 1.22e-07 | 369 | 86 | 12 | SM00349 |
| Domain | KRAB | ZNF492 ZNF852 ZNF43 ZNF549 ZNF816 ZNF510 ZNF860 ZNF468 ZNF98 ZIM3 ZNF583 ZNF879 | 1.25e-07 | 370 | 86 | 12 | IPR001909 |
| Domain | TF_IIS-rel | 3.76e-07 | 4 | 86 | 3 | IPR016492 | |
| Domain | Znf_TFIIS | 1.87e-06 | 6 | 86 | 3 | IPR001222 | |
| Domain | ZnF_C2C2 | 1.87e-06 | 6 | 86 | 3 | SM00440 | |
| Domain | ZF_TFIIS_1 | 1.87e-06 | 6 | 86 | 3 | PS00466 | |
| Domain | ZF_TFIIS_2 | 1.87e-06 | 6 | 86 | 3 | PS51133 | |
| Domain | TFIIS_C | 1.87e-06 | 6 | 86 | 3 | PF01096 | |
| Domain | TFS2M | 3.26e-06 | 7 | 86 | 3 | SM00510 | |
| Domain | TFIIS_M | 3.26e-06 | 7 | 86 | 3 | PF07500 | |
| Domain | TFIIS_cen_dom | 5.19e-06 | 8 | 86 | 3 | IPR003618 | |
| Domain | - | 5.19e-06 | 8 | 86 | 3 | 1.10.472.30 | |
| Domain | TFIIS_CENTRAL | 5.19e-06 | 8 | 86 | 3 | PS51321 | |
| Domain | TFIIS/CRSP70_N_sub | 1.11e-05 | 10 | 86 | 3 | IPR003617 | |
| Domain | TFS2N | 1.11e-05 | 10 | 86 | 3 | SM00509 | |
| Domain | Glial_neurotroph_fac_rcpt_a1/2 | 2.10e-05 | 2 | 86 | 2 | IPR017372 | |
| Domain | - | 2.61e-05 | 13 | 86 | 3 | 1.20.930.10 | |
| Domain | TFIIS_N | 2.61e-05 | 13 | 86 | 3 | PS51319 | |
| Domain | Med26 | 2.61e-05 | 13 | 86 | 3 | PF08711 | |
| Domain | TFIIS_N | 3.31e-05 | 14 | 86 | 3 | IPR017923 | |
| Domain | Thioredoxin/glutathione_Rdtase | 6.27e-05 | 3 | 86 | 2 | IPR006338 | |
| Domain | Pyr_OxRdtase_I_AS | 2.08e-04 | 5 | 86 | 2 | IPR012999 | |
| Domain | Pyr_redox_dim | 2.08e-04 | 5 | 86 | 2 | PF02852 | |
| Domain | GDNF_rcpt | 2.08e-04 | 5 | 86 | 2 | IPR003438 | |
| Domain | PYRIDINE_REDOX_1 | 2.08e-04 | 5 | 86 | 2 | PS00076 | |
| Domain | GDNF | 3.11e-04 | 6 | 86 | 2 | SM00907 | |
| Domain | GDNF | 3.11e-04 | 6 | 86 | 2 | PF02351 | |
| Domain | GDNF/GAS1 | 3.11e-04 | 6 | 86 | 2 | IPR016017 | |
| Domain | GLUTAREDOXIN_1 | 3.11e-04 | 6 | 86 | 2 | PS00195 | |
| Domain | - | 4.34e-04 | 7 | 86 | 2 | 3.30.390.30 | |
| Domain | Pyr_nucl-diS_OxRdtase_dimer | 5.76e-04 | 8 | 86 | 2 | IPR004099 | |
| Domain | FAD/NAD-linked_Rdtase_dimer | 5.76e-04 | 8 | 86 | 2 | IPR016156 | |
| Domain | Glutaredoxin | 7.39e-04 | 9 | 86 | 2 | PF00462 | |
| Domain | GLUTAREDOXIN_2 | 7.39e-04 | 9 | 86 | 2 | PS51354 | |
| Domain | SET | 8.85e-04 | 41 | 86 | 3 | PF00856 | |
| Domain | Glutaredoxin | 9.21e-04 | 10 | 86 | 2 | IPR002109 | |
| Domain | SET | 1.24e-03 | 46 | 86 | 3 | SM00317 | |
| Domain | zf-C4 | 1.24e-03 | 46 | 86 | 3 | PF00105 | |
| Domain | Znf_hrmn_rcpt | 1.24e-03 | 46 | 86 | 3 | IPR001628 | |
| Domain | Nuclear_hrmn_rcpt | 1.24e-03 | 46 | 86 | 3 | IPR001723 | |
| Domain | NUCLEAR_REC_DBD_2 | 1.24e-03 | 46 | 86 | 3 | PS51030 | |
| Domain | NUCLEAR_REC_DBD_1 | 1.24e-03 | 46 | 86 | 3 | PS00031 | |
| Domain | ZnF_C4 | 1.24e-03 | 46 | 86 | 3 | SM00399 | |
| Domain | - | 1.32e-03 | 47 | 86 | 3 | 1.10.565.10 | |
| Domain | HOLI | 1.40e-03 | 48 | 86 | 3 | SM00430 | |
| Domain | Nucl_hrmn_rcpt_lig-bd | 1.40e-03 | 48 | 86 | 3 | IPR000536 | |
| Domain | Hormone_recep | 1.40e-03 | 48 | 86 | 3 | PF00104 | |
| Domain | SET_dom | 1.58e-03 | 50 | 86 | 3 | IPR001214 | |
| Domain | SET | 1.58e-03 | 50 | 86 | 3 | PS50280 | |
| Domain | Anticodon-bd | 1.84e-03 | 14 | 86 | 2 | IPR004154 | |
| Domain | - | 2.31e-03 | 57 | 86 | 3 | 3.30.50.10 | |
| Domain | Znf_NHR/GATA | 2.42e-03 | 58 | 86 | 3 | IPR013088 | |
| Domain | EGF | 2.74e-03 | 126 | 86 | 4 | PF00008 | |
| Domain | Prtase_inh_Kunz-CS | 3.06e-03 | 18 | 86 | 2 | IPR020901 | |
| Domain | KU | 3.06e-03 | 18 | 86 | 2 | SM00131 | |
| Domain | PLAC | 3.41e-03 | 19 | 86 | 2 | PS50900 | |
| Domain | BPTI_KUNITZ_2 | 3.41e-03 | 19 | 86 | 2 | PS50279 | |
| Domain | PLAC | 3.41e-03 | 19 | 86 | 2 | IPR010909 | |
| Domain | Kunitz_BPTI | 3.41e-03 | 19 | 86 | 2 | PF00014 | |
| Domain | Pyr_redox_2 | 3.41e-03 | 19 | 86 | 2 | PF07992 | |
| Domain | BPTI_KUNITZ_1 | 3.41e-03 | 19 | 86 | 2 | PS00280 | |
| Pathway | REACTOME_RNA_POLYMERASE_II_TRANSCRIPTION | TXNRD1 TCEA1 ZNF492 ZNF600 ZNF43 USP9X ZNF549 ICE2 NR4A2 ZNF724 ZNF521 KMT2A NR4A3 RFFL ZNF510 ZNF860 NR4A1 ZNF468 ZIM3 ZNF583 PRDM1 | 5.31e-07 | 1387 | 65 | 21 | M734 |
| Pubmed | 1.51e-08 | 3 | 87 | 3 | 25899083 | ||
| Pubmed | NR4A nuclear receptors support memory enhancement by histone deacetylase inhibitors. | 1.51e-08 | 3 | 87 | 3 | 22996661 | |
| Pubmed | 1.51e-08 | 3 | 87 | 3 | 27159982 | ||
| Pubmed | Inhibition of adipocyte differentiation by Nur77, Nurr1, and Nor1. | 1.51e-08 | 3 | 87 | 3 | 18945812 | |
| Pubmed | The nuclear receptors NUR77, NURR1 and NOR1 in obesity and during fat loss. | 1.51e-08 | 3 | 87 | 3 | 22143616 | |
| Pubmed | 1.51e-08 | 3 | 87 | 3 | 16873729 | ||
| Pubmed | The orphan nuclear receptor Nur77 is a determinant of myofiber size and muscle mass in mice. | 1.51e-08 | 3 | 87 | 3 | 25605333 | |
| Pubmed | 1.51e-08 | 3 | 87 | 3 | 15964844 | ||
| Pubmed | 1.51e-08 | 3 | 87 | 3 | 28808448 | ||
| Pubmed | 1.51e-08 | 3 | 87 | 3 | 25199433 | ||
| Pubmed | 1.51e-08 | 3 | 87 | 3 | 24005216 | ||
| Pubmed | Minireview: What is Known about SUMOylation Among NR4A Family Members? | 1.51e-08 | 3 | 87 | 3 | 34437889 | |
| Pubmed | 1.51e-08 | 3 | 87 | 3 | 24753204 | ||
| Pubmed | Differential regulation of Nr4a subfamily nuclear receptors following mast cell activation. | 1.51e-08 | 3 | 87 | 3 | 21621845 | |
| Pubmed | 1.51e-08 | 3 | 87 | 3 | 10523643 | ||
| Pubmed | 1.51e-08 | 3 | 87 | 3 | 20659174 | ||
| Pubmed | 1.51e-08 | 3 | 87 | 3 | 36482877 | ||
| Pubmed | 1.51e-08 | 3 | 87 | 3 | 25917081 | ||
| Pubmed | FGF-8 stimulates the expression of NR4A orphan nuclear receptors in osteoblasts. | 1.51e-08 | 3 | 87 | 3 | 18809462 | |
| Pubmed | NR4A transcription factors limit CAR T cell function in solid tumours. | 1.51e-08 | 3 | 87 | 3 | 30814732 | |
| Pubmed | The NR4A orphan nuclear receptors: mediators in metabolism and diseases. | 1.51e-08 | 3 | 87 | 3 | 25089663 | |
| Pubmed | 1.51e-08 | 3 | 87 | 3 | 19465082 | ||
| Pubmed | 1.51e-08 | 3 | 87 | 3 | 15910281 | ||
| Pubmed | 6.04e-08 | 4 | 87 | 3 | 31152140 | ||
| Pubmed | Trained immunity induced by high-salt diet impedes stroke recovery. | 6.04e-08 | 4 | 87 | 3 | 37965920 | |
| Pubmed | Nr4a receptors are essential for thymic regulatory T cell development and immune homeostasis. | 6.04e-08 | 4 | 87 | 3 | 23334790 | |
| Pubmed | Evaluation of mRNA Expressions of TOX and NR4As in CD8+ T cells in Acute Leukemia. | 6.04e-08 | 4 | 87 | 3 | 37961948 | |
| Pubmed | 6.04e-08 | 4 | 87 | 3 | 22789442 | ||
| Pubmed | 6.04e-08 | 4 | 87 | 3 | 30089271 | ||
| Pubmed | Parathyroid hormone induces the NR4A family of nuclear orphan receptors in vivo. | 6.04e-08 | 4 | 87 | 3 | 15910753 | |
| Pubmed | 6.04e-08 | 4 | 87 | 3 | 14525795 | ||
| Pubmed | 6.04e-08 | 4 | 87 | 3 | 33665581 | ||
| Pubmed | 1.51e-07 | 5 | 87 | 3 | 1917889 | ||
| Pubmed | 1.51e-07 | 5 | 87 | 3 | 15155786 | ||
| Pubmed | 1.51e-07 | 5 | 87 | 3 | 23169579 | ||
| Pubmed | Suppression of Th2 and Tfh immune reactions by Nr4a receptors in mature T reg cells. | 1.51e-07 | 5 | 87 | 3 | 26304965 | |
| Pubmed | 1.51e-07 | 5 | 87 | 3 | 8961274 | ||
| Pubmed | 3.01e-07 | 6 | 87 | 3 | 25809189 | ||
| Pubmed | Nur77 is phosphorylated in cells by RSK in response to mitogenic stimulation. | 8.39e-07 | 8 | 87 | 3 | 16223362 | |
| Pubmed | GDNF and GFRalpha1 promote differentiation and tangential migration of cortical GABAergic neurons. | 1.79e-06 | 10 | 87 | 3 | 15748846 | |
| Pubmed | MORF4L2 USP9X SYNE1 SMC1A NR4A2 ADNP2 LRP1 ZNF521 RAB11FIP4 CTNND2 ZBTB11 ZNF583 ZMYM4 ZNF879 | 3.59e-06 | 1285 | 87 | 14 | 35914814 | |
| Pubmed | 6.19e-06 | 2 | 87 | 2 | 34248958 | ||
| Pubmed | 6.19e-06 | 2 | 87 | 2 | 9177201 | ||
| Pubmed | 6.19e-06 | 2 | 87 | 2 | 30111648 | ||
| Pubmed | Differential roles for Nr4a1 and Nr4a2 in object location vs. object recognition long-term memory. | 6.19e-06 | 2 | 87 | 2 | 23161447 | |
| Pubmed | The orphan nuclear receptor Nor1/Nr4a3 is a negative regulator of β-cell mass. | 6.19e-06 | 2 | 87 | 2 | 30696767 | |
| Pubmed | 6.19e-06 | 2 | 87 | 2 | 20411565 | ||
| Pubmed | Nuclear receptors Nur77 and Nurr1 modulate mesenchymal stromal cell migration. | 6.19e-06 | 2 | 87 | 2 | 21480782 | |
| Pubmed | NR4A3 Suppresses Lymphomagenesis through Induction of Proapoptotic Genes. | 6.19e-06 | 2 | 87 | 2 | 28249906 | |
| Pubmed | 6.19e-06 | 2 | 87 | 2 | 20668010 | ||
| Pubmed | ZNF521 sustains the differentiation block in MLL-rearranged acute myeloid leukemia. | 6.19e-06 | 2 | 87 | 2 | 28412727 | |
| Pubmed | 6.19e-06 | 2 | 87 | 2 | 15486232 | ||
| Pubmed | 6.19e-06 | 2 | 87 | 2 | 36469101 | ||
| Pubmed | The nuclear orphan receptor NR4A1 and NR4A3 as tumor suppressors in hematologic neoplasms. | 6.19e-06 | 2 | 87 | 2 | 25410408 | |
| Pubmed | 6.19e-06 | 2 | 87 | 2 | 9685180 | ||
| Pubmed | 6.19e-06 | 2 | 87 | 2 | 19153266 | ||
| Pubmed | 6.19e-06 | 2 | 87 | 2 | 38474099 | ||
| Pubmed | 6.19e-06 | 2 | 87 | 2 | 23247046 | ||
| Pubmed | Transcription factor genes and the developing eye: a genetic perspective. | 6.19e-06 | 2 | 87 | 2 | 8875254 | |
| Pubmed | 6.19e-06 | 2 | 87 | 2 | 15292355 | ||
| Pubmed | Abrogation of nuclear receptors Nr4a3 and Nr4a1 leads to development of acute myeloid leukemia. | 6.19e-06 | 2 | 87 | 2 | 17515897 | |
| Pubmed | Reduced NR4A gene dosage leads to mixed myelodysplastic/myeloproliferative neoplasms in mice. | 6.19e-06 | 2 | 87 | 2 | 21205929 | |
| Pubmed | CUG start codon generates thioredoxin/glutathione reductase isoforms in mouse testes. | 6.19e-06 | 2 | 87 | 2 | 20018845 | |
| Pubmed | 6.19e-06 | 2 | 87 | 2 | 32341238 | ||
| Pubmed | 6.19e-06 | 2 | 87 | 2 | 9259272 | ||
| Pubmed | Identification of a new brain-specific transcription factor, NURR1. | 6.19e-06 | 2 | 87 | 2 | 1491694 | |
| Pubmed | 6.19e-06 | 2 | 87 | 2 | 28637666 | ||
| Pubmed | 6.19e-06 | 2 | 87 | 2 | 36350986 | ||
| Pubmed | TIF1beta/KAP-1 is a coactivator of the orphan nuclear receptor NGFI-B/Nur77. | 6.73e-06 | 15 | 87 | 3 | 19321449 | |
| Pubmed | 8.27e-06 | 16 | 87 | 3 | 28170423 | ||
| Pubmed | HIV-1 Tat acts as a processivity factor in vitro in conjunction with cellular elongation factors. | 1.00e-05 | 17 | 87 | 3 | 1559613 | |
| Pubmed | 1.42e-05 | 19 | 87 | 3 | 12878679 | ||
| Pubmed | 1.85e-05 | 3 | 87 | 2 | 10774729 | ||
| Pubmed | 1.85e-05 | 3 | 87 | 2 | 23552735 | ||
| Pubmed | 1.85e-05 | 3 | 87 | 2 | 21979916 | ||
| Pubmed | 1.85e-05 | 3 | 87 | 2 | 25092869 | ||
| Pubmed | 1.85e-05 | 3 | 87 | 2 | 12490080 | ||
| Pubmed | 1.85e-05 | 3 | 87 | 2 | 15589513 | ||
| Pubmed | 1.85e-05 | 3 | 87 | 2 | 7877627 | ||
| Pubmed | 1.85e-05 | 3 | 87 | 2 | 32958255 | ||
| Pubmed | 1.85e-05 | 3 | 87 | 2 | 29343483 | ||
| Pubmed | 1.85e-05 | 3 | 87 | 2 | 15591535 | ||
| Pubmed | Deficiency of the NR4A orphan nuclear receptor NOR1 decreases monocyte adhesion and atherosclerosis. | 1.85e-05 | 3 | 87 | 2 | 20558821 | |
| Pubmed | Redox regulation of cell signaling by selenocysteine in mammalian thioredoxin reductases. | 1.85e-05 | 3 | 87 | 2 | 10455115 | |
| Pubmed | Selenoprotein oxidoreductase with specificity for thioredoxin and glutathione systems. | 1.85e-05 | 3 | 87 | 2 | 11259642 | |
| Pubmed | Functional redundancy of the Nur77 and Nor-1 orphan steroid receptors in T-cell apoptosis. | 1.85e-05 | 3 | 87 | 2 | 9155013 | |
| Pubmed | 1.85e-05 | 3 | 87 | 2 | 8566795 | ||
| Pubmed | 1.85e-05 | 3 | 87 | 2 | 26634653 | ||
| Pubmed | 1.85e-05 | 3 | 87 | 2 | 12223510 | ||
| Pubmed | 1.85e-05 | 3 | 87 | 2 | 17825269 | ||
| Pubmed | 1.85e-05 | 3 | 87 | 2 | 30106181 | ||
| Pubmed | 1.85e-05 | 3 | 87 | 2 | 29414782 | ||
| Pubmed | 1.85e-05 | 3 | 87 | 2 | 26148973 | ||
| Pubmed | 1.85e-05 | 3 | 87 | 2 | 10069331 | ||
| Pubmed | Genetic association of the GDNF alpha-receptor genes with schizophrenia and clozapine response. | 1.85e-05 | 3 | 87 | 2 | 20116071 | |
| Pubmed | 1.85e-05 | 3 | 87 | 2 | 12807892 | ||
| Pubmed | 1.85e-05 | 3 | 87 | 2 | 23881409 | ||
| Pubmed | Genome-scale study of transcription factor expression in the branching mouse lung. | 2.48e-05 | 67 | 87 | 4 | 22711520 | |
| Pubmed | Molecular cloning and characterization of cDNA for eukaryotic transcription factor S-II. | 3.70e-05 | 4 | 87 | 2 | 3346229 | |
| Pubmed | 3.70e-05 | 4 | 87 | 2 | 9749804 | ||
| Cytoband | 19q13.41 | 1.61e-05 | 78 | 88 | 4 | 19q13.41 | |
| Cytoband | 12q23-q24.1 | 5.42e-05 | 6 | 88 | 2 | 12q23-q24.1 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr19p12 | 9.31e-05 | 122 | 88 | 4 | chr19p12 | |
| Cytoband | 19p12 | 7.09e-04 | 90 | 88 | 3 | 19p12 | |
| Cytoband | Xq22 | 8.18e-04 | 22 | 88 | 2 | Xq22 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr20q13 | 1.34e-03 | 422 | 88 | 5 | chr20q13 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr19q13 | 2.08e-03 | 1192 | 88 | 8 | chr19q13 | |
| GeneFamily | Zinc fingers C2H2-type|ZF class homeoboxes and pseudogenes | ZNF492 ZNF800 ZNF600 ZNF117 ZNF852 ZNF341 ZNF43 ZNF549 ZNF335 ADNP2 ZNF816 ZNF521 ZBTB41 ZNF510 ZNF860 SNAI1 ZNF468 ZBTB11 ZNF98 ZIM3 ZNF583 ZNF879 PRDM1 | 8.85e-17 | 718 | 63 | 23 | 28 |
| GeneFamily | Nuclear hormone receptors | 6.63e-04 | 49 | 63 | 3 | 71 | |
| GeneFamily | Selenoproteins | 3.40e-03 | 25 | 63 | 2 | 890 | |
| GeneFamily | PHD finger proteins | 3.82e-03 | 90 | 63 | 3 | 88 | |
| Coexpression | GSE17974_0H_VS_0.5H_IN_VITRO_ACT_CD4_TCELL_DN | 3.61e-06 | 192 | 87 | 7 | M4154 | |
| ToppCell | PBMC-Control-Myeloid-cDC-cDC-cDC_6|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.06e-07 | 191 | 88 | 7 | 6cda82a994f4b205cf54590c979d7c9f3be2b4c8 | |
| ToppCell | PBMC-Control-Myeloid-cDC-cDC-cDC_6|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.06e-07 | 191 | 88 | 7 | 4257f02856f3510981e9f84d465d91448d6126e2 | |
| ToppCell | PBMC-Control-Myeloid-cDC-cDC-cDC_7|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.06e-07 | 191 | 88 | 7 | 2699e9bb872f2b561bb976dfdc2746e359bc9daf | |
| ToppCell | (3)_MNP-(3)_DC_2|(3)_MNP / Lung cell shreds - cell class (v4) and cell subclass (v4) | 1.06e-07 | 191 | 88 | 7 | 3ff163484af8c12ef4eef87246cf044257fd2547 | |
| ToppCell | PBMC-Control-Myeloid-cDC-cDC-cDC_7|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.06e-07 | 191 | 88 | 7 | 4b94c8b0183ae07d173646b7e7e1d9db04ec9637 | |
| ToppCell | Control-cDC-|Control / Disease condition and Cell class | 1.22e-07 | 195 | 88 | 7 | a2b4d9473eff73f088b247ce43e66f013622471e | |
| ToppCell | Control-cDC|Control / Disease condition and Cell class | 1.22e-07 | 195 | 88 | 7 | b96acdd22dd3885af69328f170ea871a0d570034 | |
| ToppCell | COVID-19_Severe-cDC|COVID-19_Severe / disease group, cell group and cell class | 1.22e-07 | 195 | 88 | 7 | 6419090b19de7b5d5140eaecf231860273da2c0d | |
| ToppCell | mild_COVID-19-cDC|World / disease group, cell group and cell class (v2) | 1.30e-07 | 197 | 88 | 7 | 63e7b040c64f1e28b8db79980c7b580caa7d1b95 | |
| ToppCell | BAL-Control-cDC_5|Control / Compartment, Disease Groups and Clusters | 1.30e-07 | 197 | 88 | 7 | 8a3fe59be3ed1f0254cc8c60b99c840193370efb | |
| ToppCell | Entopeduncular-Endothelial-MURAL-M1(Rgs5Acta2)-M1_1-MURAL_Mural.Rgs5Acta2.Junb_(Mural,_IEG+)|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 6.76e-07 | 156 | 88 | 6 | 029ba0832ee9c4a2c85620e4df2260e02d86b45c | |
| ToppCell | Entopeduncular-Endothelial-MURAL-M1(Rgs5Acta2)-M1_1-MURAL_Mural.Rgs5Acta2.Junb_(Mural,_IEG+)-|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 6.76e-07 | 156 | 88 | 6 | 5df19a235843829f5a1a90ca21b0964ef8b4e115 | |
| ToppCell | metastatic_Lymph_Node-Myeloid_cells-CD1c+_DCs|metastatic_Lymph_Node / Location, Cell class and cell subclass | 1.66e-06 | 182 | 88 | 6 | 551d301adfb4d5046c5f60f6996450621b04e9b2 | |
| ToppCell | PBMC-Mild-cDC_5|Mild / Compartment, Disease Groups and Clusters | 1.94e-06 | 187 | 88 | 6 | 0afef5baf3752314dbfb024790347d5e51f9b84b | |
| ToppCell | PBMC-Mild-Myeloid-cDC-cDC-cDC_8|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.00e-06 | 188 | 88 | 6 | 8431991e68b8e9c5eb72212460f6da679ea3b85a | |
| ToppCell | PBMC-Mild-Myeloid-cDC-cDC-cDC_8|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 2.00e-06 | 188 | 88 | 6 | d8f10b3ad11bc99a63f44560e39791085256e5c8 | |
| ToppCell | PBMC-Mild-Myeloid-cDC-cDC-cDC_5|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.07e-06 | 189 | 88 | 6 | c81b38cda4525254fe4fa137a4c9bc9abe0363bb | |
| ToppCell | PBMC-Mild-Myeloid-cDC-cDC-cDC_5|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 2.07e-06 | 189 | 88 | 6 | 807922b5ea0faddd3abfa9ec1b53f3f2b00e61bf | |
| ToppCell | PBMC-Severe-Myeloid-cDC-cDC-cDC_5|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 2.20e-06 | 191 | 88 | 6 | 92c5a26b90a55831039220341d863cf2940f3c9b | |
| ToppCell | PBMC-Severe-Myeloid-cDC-cDC-cDC_5|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.26e-06 | 192 | 88 | 6 | 6184163dbfca882824cb266bb9030d9f79e3acb0 | |
| ToppCell | PBMC-Control-Myeloid-cDC-cDC-cDC_5|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 2.26e-06 | 192 | 88 | 6 | dfb9101622f7d2f2c392e850cff07becfc8c655e | |
| ToppCell | PBMC-Control-Myeloid-cDC-cDC-cDC_5|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.26e-06 | 192 | 88 | 6 | d39133cf1a20af6f2970188630fc3b27a4cfc9c5 | |
| ToppCell | 367C-Myeloid-Dendritic-cDC2|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 2.33e-06 | 193 | 88 | 6 | 940e9a419d0de1f9e72b5cc9c86684057003be58 | |
| ToppCell | BAL-Control-Myeloid-cDC-cDC-cDC_5|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 2.33e-06 | 193 | 88 | 6 | 704378de39e1b6f108ab5b0ecbd594d414ec8ae4 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Lymphoid-CD4/CD8-CD8_NK_sig-C|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.40e-06 | 194 | 88 | 6 | 6be74e4ba631b0c46cef2c580553f4c1ed29579e | |
| ToppCell | BAL-Control-Myeloid-cDC-cDC-cDC_5|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.40e-06 | 194 | 88 | 6 | 36f8ae4f2b3bf802f6ff0e9fc79e7f170f96ae8b | |
| ToppCell | 343B-Myeloid-Dendritic-cDC2|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 2.40e-06 | 194 | 88 | 6 | ccb04f0788c98e0f63f18b09484d75ac536412a1 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_2_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.48e-06 | 195 | 88 | 6 | ff0aa455e9844a6d7ae57ff59fb6cea825cf1fc2 | |
| ToppCell | metastatic_Lymph_Node-Myeloid_cells-CD163+CD14+_DCs|Myeloid_cells / Location, Cell class and cell subclass | 2.48e-06 | 195 | 88 | 6 | 7fb5c0911ff09580515d1a1827d7249d6242630c | |
| ToppCell | COVID-19_Moderate-cDC|World / disease group, cell group and cell class | 2.55e-06 | 196 | 88 | 6 | 92a236adf386f05d020b1954bbdc5bd32346cbf0 | |
| ToppCell | tumor_Lung-Myeloid_cells-CD163+CD14+_DCs|Myeloid_cells / Location, Cell class and cell subclass | 2.55e-06 | 196 | 88 | 6 | 7aa6778b78a8549dd4d0a5278ef8017334b00c38 | |
| ToppCell | COVID-19_Mild-cDC|COVID-19_Mild / Disease condition and Cell class | 2.63e-06 | 197 | 88 | 6 | 09045845891de79164124afb6c632e2838906006 | |
| ToppCell | normal_Lymph_Node-Myeloid_cells-CD1c+_DCs|Myeloid_cells / Location, Cell class and cell subclass | 2.63e-06 | 197 | 88 | 6 | 2b3cd318c988364adcba4441444045914d58fe46 | |
| ToppCell | COVID-19_Mild-cDC-|COVID-19_Mild / Disease condition and Cell class | 2.63e-06 | 197 | 88 | 6 | 61d6dd023b2ba2bc76f17c06f7c30434ed865171 | |
| ToppCell | mLN-B_cell-B_cell_memory|B_cell / Region, Cell class and subclass | 2.70e-06 | 198 | 88 | 6 | e2c63ca9f82f8524447e398b11a676b22d2f58ce | |
| ToppCell | tumor_Lung-Myeloid_cells-CD1c+_DCs|Myeloid_cells / Location, Cell class and cell subclass | 2.70e-06 | 198 | 88 | 6 | edd8ad006c4c7516491e52cc8adad20297837e5b | |
| ToppCell | COVID-19_Severe-cDC|World / disease group, cell group and cell class | 2.70e-06 | 198 | 88 | 6 | c452334249f047265ae89dcabe7de446d968cae6 | |
| ToppCell | Bronchial-NucSeq-Stromal-Fibroblastic-Fibro_perichondrial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.78e-06 | 199 | 88 | 6 | abd6117f8a3d7e798d8471c16d97b34aaf50fc9c | |
| ToppCell | Control-Control-Myeloid-cDC|Control / Disease, condition lineage and cell class | 2.86e-06 | 200 | 88 | 6 | 1375d199320feb85ba06e74b10df6521e790addf | |
| ToppCell | COVID-19-COVID-19_Severe-Myeloid-cDC|COVID-19_Severe / Disease, condition lineage and cell class | 2.86e-06 | 200 | 88 | 6 | e7b808d8ed65343a4345fafb03015fe4f7ce302f | |
| ToppCell | Tracheal-NucSeq-Stromal-Fibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.86e-06 | 200 | 88 | 6 | b4ccffdd79526c85e5273d27b668dbddcddba1ee | |
| ToppCell | Biopsy_Other_PF-Immune-cDCs|Biopsy_Other_PF / Sample group, Lineage and Cell type | 2.86e-06 | 200 | 88 | 6 | 8e455f685f0a9c63e83d6d339d7767f0e9841c6e | |
| ToppCell | Parenchymal-10x5prime-Immune_Myeloid-Macrophage_other-Macrophage_intermediate|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 2.86e-06 | 200 | 88 | 6 | 09bac15df511687ff336c1e7a67d980c6c281f79 | |
| ToppCell | Tracheal-NucSeq-Stromal-Fibroblastic-Fibro_adventitial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.86e-06 | 200 | 88 | 6 | 0c25d56292b9e5fefa4521b72635449be1ffd6fe | |
| ToppCell | RA-15._Ventricular_Cardiomyocyte_III|World / Chamber and Cluster_Paper | 8.06e-06 | 138 | 88 | 5 | 5a713f24f633de463ef47ca37fbb2bb60c7fdb77 | |
| ToppCell | 343B-Myeloid-Macrophage-SPP1+_Macrophage_2|Macrophage / Donor, Lineage, Cell class and subclass (all cells) | 1.37e-05 | 154 | 88 | 5 | 874b1220337276489a89fcc9a39bc81ba6b68baf | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Hpse_Sema3c|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.42e-05 | 155 | 88 | 5 | 5c7b68b59244525e3714806c205a57a2daebf423 | |
| ToppCell | BAL-Severe-Myeloid-cDC-cDC-cDC_8|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.70e-05 | 161 | 88 | 5 | 7e0b8119cea208c0b4a0dffdf94ff6137d0b4c90 | |
| ToppCell | BAL-Severe-Myeloid-cDC-cDC-cDC_8|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.75e-05 | 162 | 88 | 5 | 2fd6e8f48b48d509a7533cec2f79089513c34a2f | |
| ToppCell | normal_Lymph_Node-Myeloid_cells-Monocytes|Myeloid_cells / Location, Cell class and cell subclass | 1.80e-05 | 163 | 88 | 5 | 7d7f18e5c99be125e95bc180823430291b770d05 | |
| ToppCell | normal_Lung-Myeloid_cells-CD163+CD14+_DCs|Myeloid_cells / Location, Cell class and cell subclass | 1.97e-05 | 166 | 88 | 5 | 07b498eb341abec02a3ccaae320bdbb5cd6883c5 | |
| ToppCell | COVID-19-Myeloid-MoAM5,_CCL3L1|Myeloid / Condition, Lineage and Cell class | 2.09e-05 | 168 | 88 | 5 | ea465152ea31391b63c02425beafa9a4f51f6703 | |
| ToppCell | facs-Mammary_Gland-Mammary_Gland-21m-Mesenchymal|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.15e-05 | 169 | 88 | 5 | bb43abad2c049b7f4d307737347290e01b3339a3 | |
| ToppCell | facs-Mammary_Gland-Mammary_Gland-21m-Mesenchymal-stromal_cell|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.15e-05 | 169 | 88 | 5 | 5f18e3f40a5b1b167903f37516ec8181e889c7c5 | |
| ToppCell | facs-Mammary_Gland-Mammary_Gland-21m-Mesenchymal-stromal_cell|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.15e-05 | 169 | 88 | 5 | 8bfa2d3bb541d02f55d7c95b8fd156c8403befca | |
| ToppCell | 5'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-elicited_macrophage-Monocyte-derived_macrophage-Monocyte-derived_macrophage_L.1.2.5.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.27e-05 | 171 | 88 | 5 | 5e93c76ee60f9d0590ebb140812653a5e1369417 | |
| ToppCell | 3'-Broncho-tracheal-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.34e-05 | 172 | 88 | 5 | e37c0b5b547a7345179ab258dd2141fec7064c17 | |
| ToppCell | COVID-19-Myeloid-MoAM5,_CCL3L1|COVID-19 / Condition, Lineage and Cell class | 2.40e-05 | 173 | 88 | 5 | 502f888b7684ed39f5c577eedcacf673ae81d39e | |
| ToppCell | facs-SCAT-Fat-24m-Lymphocytic-NK_cell|SCAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.54e-05 | 175 | 88 | 5 | d82153bdb0c5cca96485d6b0579440f9c9e3abe2 | |
| ToppCell | droplet-Kidney-nan-21m-Lymphocytic-nan|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.61e-05 | 176 | 88 | 5 | feafc757e7aa4f17128ff34886beb2fd3461c9ea | |
| ToppCell | BAL-Control-Myeloid-cDC-cDC-cDC_6|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.68e-05 | 177 | 88 | 5 | 3a150dcaefa342d49968b42c7cdb1fbb633adcd0 | |
| ToppCell | BAL-Control-Myeloid-cDC-cDC-cDC_6|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 2.68e-05 | 177 | 88 | 5 | c9e5820ff0bc7ad1adcfb2651713fdfc58bced56 | |
| ToppCell | TCGA-Ovary-Primary_Tumor-Ovarian_Carcinoma-Serous_Cystadenocarcinoma-6|TCGA-Ovary / Sample_Type by Project: Shred V9 | 2.75e-05 | 178 | 88 | 5 | 142879e9393e721f9b05a6bb46995c9d6d713c95 | |
| ToppCell | normal_Lung-Myeloid_cells-CD163+CD14+_DCs|normal_Lung / Location, Cell class and cell subclass | 2.75e-05 | 178 | 88 | 5 | b6dacaad09bf4384d0d4c926fbf769e74a8ec9a9 | |
| ToppCell | CD8+_Memory_T_cell-FLU-5|CD8+_Memory_T_cell / cell class, Virus stimulation and cluster | 2.83e-05 | 179 | 88 | 5 | 7f18dffa85285599662edbcd3f32ab42672bffb8 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Myeloid-Dendritic-conventional_dendritic_cell-DC_c2-CD1C|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.98e-05 | 181 | 88 | 5 | c8286a7ac8e3cc5aa7e92b043a08435294ea686f | |
| ToppCell | mild_COVID-19-NK_CD56bright|World / disease group, cell group and cell class (v2) | 3.14e-05 | 183 | 88 | 5 | 9a4899afac0f91203209392c5f67b3d0aa356b86 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.22e-05 | 184 | 88 | 5 | e061e85c4bb19f49f6451ddd7a9077d7378ee365 | |
| ToppCell | 3'-Broncho-tracheal-Immune_Myeloid-Myeloid_macrophage-elicited_macrophage-Monocyte-derived_macrophage-Monocyte-derived_macrophage_L.1.2.5.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.22e-05 | 184 | 88 | 5 | d1ea2b60fb1ca1a0b809d131310c43903a9e84ce | |
| ToppCell | normal-na-Myeloid-conventional_dendritic_cell-male|normal / PBMC cell types (v2) per disease, treatment status, and sex | 3.31e-05 | 185 | 88 | 5 | 67e881a89a491665b8c612fff084c202c0c79235 | |
| ToppCell | Smart-seq2-spleen_(Smart-seq2)-lymphocytic-innate_lymphocytic|spleen_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 3.40e-05 | 186 | 88 | 5 | fc0b488c201a32d829047b58460297df2818b45d | |
| ToppCell | NS-moderate-d_0-4-Myeloid-Non-resident_Macrophage|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 3.48e-05 | 187 | 88 | 5 | fcc32dbc9c5ae6176f154715a3e73aa32d78ad64 | |
| ToppCell | 3'_v3-blood-Myeloid_Dendritic-DC2|blood / Manually curated celltypes from each tissue | 3.48e-05 | 187 | 88 | 5 | 9f3db9f0e5de34aeabfe5984f675bc7a65435df7 | |
| ToppCell | COVID-19-kidney-Fibroblast-1|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.48e-05 | 187 | 88 | 5 | 76bfe8c42430a230a8bdf299575c444fb7780f24 | |
| ToppCell | ILEUM-non-inflamed-(1)_T_cell-(1)_T_(gd)|(1)_T_cell / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 3.48e-05 | 187 | 88 | 5 | e5713a7bda53d1d5178ab4e0dbadc2292b6005bc | |
| ToppCell | Smart-seq2-spleen_(Smart-seq2)-lymphocytic-innate_lymphocytic-mature_NK_T_cell|spleen_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 3.48e-05 | 187 | 88 | 5 | 6981b856187a2e689260ecb7d0a1193a374ee9b9 | |
| ToppCell | 3'_v3-blood-Myeloid_Dendritic-DC1|blood / Manually curated celltypes from each tissue | 3.57e-05 | 188 | 88 | 5 | 411d4dd5c9dee7ebd8db352640cf009e7b033ba9 | |
| ToppCell | Control-Fibroblasts-Adventitial_FB|Control / group, cell type (main and fine annotations) | 3.57e-05 | 188 | 88 | 5 | 706a26c372add839d947749f0521a0e1f5c9b0ec | |
| ToppCell | droplet-Limb_Muscle-nan-3m-Mesenchymal-nan|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.57e-05 | 188 | 88 | 5 | 7191087d8754f5e8700e3d744cd920ee26db1e57 | |
| ToppCell | metastatic_Lymph_Node-Myeloid_cells-CD163+CD14+_DCs|metastatic_Lymph_Node / Location, Cell class and cell subclass | 3.57e-05 | 188 | 88 | 5 | 5d12afb483d028ca02b3b4215131f6128e8bcd48 | |
| ToppCell | droplet-Kidney-KIDNEY-30m-Mesenchymal-nan|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.66e-05 | 189 | 88 | 5 | 544d95df910f1b276995624509a7e41b219baca0 | |
| ToppCell | LV-14._Fibroblast_III|World / Chamber and Cluster_Paper | 3.66e-05 | 189 | 88 | 5 | 3922135d1f6fc768d71ba3b465585fead6ea68a8 | |
| ToppCell | facs-Mammary_Gland-Mammary_Gland-18m-Epithelial|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.76e-05 | 190 | 88 | 5 | 92456f6f7eced6e4c4371f495254a65d061c8d0b | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.76e-05 | 190 | 88 | 5 | 1121eb607a984c59fbffe7220837fc178745aa55 | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_2_cell-D175|Adult / Lineage, Cell type, age group and donor | 3.76e-05 | 190 | 88 | 5 | 7dcca3469f3a3b70db0420cb94f7765f39492f06 | |
| ToppCell | BAL-Control-Lymphocyte-B-B_cell|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.76e-05 | 190 | 88 | 5 | da7341a8a423e5fe4d8e733d8e50c10a3318ac1c | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.76e-05 | 190 | 88 | 5 | 048b581e3f7ea9fc2f87c0532974bba85c7292c2 | |
| ToppCell | BAL-Control-Lymphocyte-B-B_cell-B_cell|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.76e-05 | 190 | 88 | 5 | 42312f7d79fe889397d32910b625793e2535cc26 | |
| ToppCell | BAL-Control-Lymphocyte-B-B_cell-B_cell-B_activate-7|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.76e-05 | 190 | 88 | 5 | 682418a7a2096743112eae3790d40e7e600612c0 | |
| ToppCell | ILEUM|World / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 3.76e-05 | 190 | 88 | 5 | 4395dbd18c14d491f5066a2ddac438a16b1fd7c3 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.85e-05 | 191 | 88 | 5 | a6c57627077fa980b7ec1d3894b5f31bfb11b738 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-DC-cDC2-G|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.85e-05 | 191 | 88 | 5 | 7bad04f8afa949ea952c5c0d71eec43271ade680 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.85e-05 | 191 | 88 | 5 | 8f6d592edc32fdb901af30501d4360512334e8c2 | |
| ToppCell | droplet-Kidney-nan-18m-Mesenchymal|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.95e-05 | 192 | 88 | 5 | 38d7a24ae205ef91ed2e0f402d8022f2a9cdb243 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.95e-05 | 192 | 88 | 5 | bc84b9ce01b4d826a682842ab8a395dac9b91183 | |
| ToppCell | Bronchial_Biopsy-Epithelial-Ciliated_1|Bronchial_Biopsy / Tissue, Lineage and Cell class of Lung Cells from 10X | 3.95e-05 | 192 | 88 | 5 | be592e661367affced9ebe80849b466e6adb3a34 | |
| ToppCell | droplet-Kidney-nan-18m-Mesenchymal-Stroma____fibroblast|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.95e-05 | 192 | 88 | 5 | 04d155897ed075c359933080e36a4ab2150b6e9f | |
| ToppCell | ILEUM-non-inflamed-(2)_B_cell-(2)_Memory_B_cells|(2)_B_cell / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 3.95e-05 | 192 | 88 | 5 | 37d0d0fdd6bc3114d546020b472b6df9392392f4 | |
| ToppCell | 356C-Myeloid-Dendritic-cDC2|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 3.95e-05 | 192 | 88 | 5 | a7ccbea7c90c070d279d7ad3f2b5b7c0e3efd890 | |
| ToppCell | 367C-Myeloid-Monocyte|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 3.95e-05 | 192 | 88 | 5 | 26326d7c3d907d754e85e128b7d8a52e90863f3f | |
| Disease | Growth Deficiency and Mental Retardation with Facial Dysmorphism | 7.26e-06 | 2 | 80 | 2 | C1854630 | |
| Disease | Myeloid Leukemia | 1.52e-05 | 18 | 80 | 3 | C0023470 | |
| Disease | Leukemia, Monocytic, Chronic | 1.52e-05 | 18 | 80 | 3 | C0023466 | |
| Disease | prostate cancer (is_marker_for) | 6.76e-05 | 156 | 80 | 5 | DOID:10283 (is_marker_for) | |
| Disease | Parkinsonism (biomarker_via_orthology) | 1.08e-04 | 34 | 80 | 3 | DOID:0080855 (biomarker_via_orthology) | |
| Disease | Cornelia De Lange Syndrome | 2.01e-04 | 8 | 80 | 2 | C0270972 | |
| Disease | Schizophrenia | 6.41e-04 | 883 | 80 | 9 | C0036341 | |
| Disease | Autosomal recessive primary microcephaly | 7.45e-04 | 15 | 80 | 2 | cv:C3711387 | |
| Disease | migraine without aura, susceptibility to, 4 | 8.50e-04 | 16 | 80 | 2 | MONDO_0011847 | |
| Disease | Intellectual Disability | 1.37e-03 | 447 | 80 | 6 | C3714756 | |
| Disease | physical activity | 1.78e-03 | 88 | 80 | 3 | EFO_0003940 | |
| Disease | partial thromboplastin time | 1.93e-03 | 24 | 80 | 2 | EFO_0004310 | |
| Disease | Neurodevelopmental Disorders | 2.09e-03 | 93 | 80 | 3 | C1535926 | |
| Disease | myocardial infarction (is_implicated_in) | 2.50e-03 | 99 | 80 | 3 | DOID:5844 (is_implicated_in) | |
| Disease | phospholipid measurement, intermediate density lipoprotein measurement | 2.50e-03 | 99 | 80 | 3 | EFO_0004639, EFO_0008595 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| KKKNPCNAEFQNFCI | 141 | P15514 | |
| KNKEKKCSYTEDAQC | 301 | P02749 | |
| KVQNKLDGCCYAVKR | 606 | Q9P2K8 | |
| NCNKCIYFEAKKKQD | 111 | Q8TDN6 | |
| YGKANDDNKIALKNC | 621 | Q9UQB3 | |
| NKLCCKSCNLYNNLT | 1086 | O95450 | |
| YCKKCNANASSQDAL | 216 | Q6IQ32 | |
| EASNSNKKCKRYFNE | 11 | A0A1B0GUU1 | |
| NENFKKNVLSAVCYC | 336 | Q96P65 | |
| DVYCSQCCKKINLLN | 271 | Q86YS3 | |
| QKNAKYICLANKDCP | 296 | P22736 | |
| KLNLAQKCFKNCYGE | 306 | Q9Y5A7 | |
| CNMKNNFICKYSDEK | 176 | Q6UX15 | |
| LKCSQKCDQNKFSVK | 1231 | Q07954 | |
| YCEKVKQLKLCQLSQ | 1736 | Q8N6G6 | |
| NRIYDSKKCCYTCKN | 8276 | Q7Z5P9 | |
| VKANCSKDDFLFNCK | 486 | Q8IXT1 | |
| NDVSDLCKLENKQYC | 601 | Q8IXT1 | |
| GNCKYKVDCACLKEN | 451 | Q8IZD2 | |
| CRKNRCNSIGYNAKK | 311 | Q9Y5X9 | |
| EYANCKKSQGNVDNK | 161 | Q15014 | |
| QQNSCYIKNKEIFCK | 106 | Q9UPM6 | |
| KKKQQLSVCNKLCYA | 36 | Q8NA29 | |
| CSQNKCNFYDNKDLE | 241 | P10619 | |
| KFLQNSAKKCAQDYN | 151 | Q659A1 | |
| DAAKACNLDDICKKY | 156 | P56159 | |
| KACNLNDNCKKLRSS | 166 | O00451 | |
| EQKCQLSYELNCSGK | 551 | Q5T0N1 | |
| LNFYCDSCKAKLQEQ | 641 | Q5JV73 | |
| KQCSHQISACNKDIY | 101 | P03951 | |
| AKNCVFLDDKKVYCQ | 1961 | Q03164 | |
| KNSCEYKLTGLQQQC | 341 | Q9BXX0 | |
| KLYAKKECNEDCNFK | 126 | P21781 | |
| AEAKLKKNRCANCFD | 61 | Q9UJW0 | |
| TKNQRDCKLTCNYGN | 191 | Q8IX30 | |
| LQKCVFSYNSNCQEK | 211 | Q6NT55 | |
| NFQSKANCLNTCKNK | 116 | O95925 | |
| VQKNAKYVCLANKNC | 291 | P43354 | |
| QKNAKYVCLANKNCP | 321 | Q92570 | |
| ANAYHCEKCNKKVDT | 1766 | Q93008 | |
| CKQLLQDEKAKCNKY | 541 | Q86VP1 | |
| KQCLKDKQALQDCAS | 2501 | Q8NF91 | |
| SYDNACQIKEASCQK | 201 | Q9UIK5 | |
| NTARKQTCLDCKKNF | 56 | Q8WZ73 | |
| LIKNCDSKSQKYNCL | 431 | Q86V20 | |
| DNCYDQAKKLDSCKF | 71 | P04054 | |
| LKKQNGKIKYECNVC | 566 | O75626 | |
| CKKKNCTYTQVQTRS | 266 | P23193 | |
| IGNKCQRCTNSEKKY | 81 | Q8TAV0 | |
| KCLQANSYMESKCQA | 16 | P56277 | |
| RDNNKCYAKIICNTK | 566 | Q16881 | |
| KDLQARKAFNCKYCN | 146 | O95863 | |
| KIHNAKKSYQCNECE | 271 | Q96PE6 | |
| KKSYQCNECEKSFRQ | 276 | Q96PE6 | |
| DNAVYKCVKCVNKYS | 536 | Q9BYN7 | |
| LKQVKDYIKQCSKCQ | 106 | O95625 | |
| NCTACEKAFIYKNKL | 586 | Q6P9A3 | |
| KCKECGKAFNQCSNL | 591 | A8MTY0 | |
| KCNECGKVFNQKAYL | 91 | Q9H963 | |
| IYNKNISQKDCDCLH | 56 | Q9NQ34 | |
| SCKSICKNYNDLQIA | 116 | Q9HAI6 | |
| CHCKSSQKNILYLDK | 386 | C9JQI7 | |
| NNYLTKEECLKKCAT | 76 | O43291 | |
| KKAELIKGNYKCNVC | 921 | Q96K83 | |
| YKCQICNQSFRIKKT | 696 | Q5SVQ8 | |
| NQCVNDKNYKDALSK | 631 | Q07617 | |
| KKALQYACGNALVCD | 606 | Q14683 | |
| DLFQCSKCKKKNCTY | 306 | O75764 | |
| SKCKKKNCTYNQVQT | 311 | O75764 | |
| NKVTDNKCIACQAAK | 671 | P49790 | |
| YKCKECAKAFNQSSN | 286 | P17038 | |
| NNACDNIAKISKYKR | 511 | Q9P255 | |
| KPYKCNECAKAFNQS | 241 | Q6ZMS4 | |
| EKPYKCNDCEKAFNQ | 481 | B4DU55 | |
| KNKNKQLRNYCHSCN | 431 | Q5GH77 | |
| KCKECGKAYNEASNL | 211 | A6NK75 | |
| CNNACDNIAKISKYK | 551 | A6NK75 | |
| ENNTCYAKIICNKFD | 561 | Q86VQ6 | |
| YKCEKCVRAFNQASK | 221 | Q03924 | |
| CNKIGKAFNDKANCV | 256 | Q9Y2H8 | |
| LYCKLCKRQFTSKQN | 486 | Q2TB10 | |
| DQVDKCYKCSVKQGQ | 331 | Q9UPP1 | |
| CGKCRKKNCTYTQVQ | 261 | Q15560 | |
| KLYKCNDCHKVFSNA | 396 | A6NHJ4 | |
| EKPYKCNECDKAFNQ | 271 | Q6ZNG1 | |
| QCSQCSFASKNKKDL | 1076 | Q9H4Z2 | |
| KQCKCDVCGKVFNQK | 241 | Q5VIY5 | |
| YQCKECKKAFSQIAH | 296 | Q96ND8 | |
| CGKNCSDEYKKINNV | 711 | Q5VZL5 | |
| GTNKVYFKQLCCKCQ | 246 | A6NP61 | |
| EYKCDVCGKIFNQKQ | 256 | Q0VGE8 | |
| YCNLKDKCNKFHVCK | 181 | Q96H79 |